VASCULAR SOLUTIONS INC 4
4 · VASCULAR SOLUTIONS INC · Filed Feb 6, 2015
Insider Transaction Report
Form 4
Saucedo Jorge
Director
Transactions
- Exercise/Conversion
Common Stock
2015-02-05$7.88/sh+10,000$78,800→ 28,006 total - Sale
Common Stock
2015-02-05$27.36/sh−10,000$273,600→ 18,006 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-02-05−10,000→ 0 totalExercise: $7.88Exp: 2016-04-18→ Common Stock (10,000 underlying)
Holdings
- 18,006
Common Stock
- 10,000
Stock Option (Right to Buy)
Exercise: $9.41Exp: 2017-04-24→ Common Stock (10,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $6.36Exp: 2018-04-22→ Common Stock (10,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $6.39Exp: 2019-04-21→ Common Stock (10,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $9.61Exp: 2020-04-22→ Common Stock (10,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $11.72Exp: 2021-04-22→ Common Stock (10,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $11.63Exp: 2022-05-04→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $27.25 to $27.65 per share. Dr. Saucedo has provided to the Company and, upon request, will provide any security holder of the Company or the SEC staff information regarding the number of shares sold at each price within that range.
- [F2]100% fully vested.